News

Zacks Investment Research on MSN3h

Oncobiologics, Inc. (OTLK) Reports Q3 Loss, Lags Revenue Estimates

Oncobiologics, Inc. (OTLK) came out with a quarterly loss of $0.44 per share versus the Zacks Consensus Estimate of a loss of $0.42. This compares to a loss of $0.83 per share a year ago. These ...
pharmaphorum7h

Texas suit claims Lilly bribed providers to prescribe drugs

Eli Lilly has been accused of giving illegal inducements to encourage medical providers in Texas to prescribe its medicines ...